Abstract 3919: Liquid biopsy derived organoids as a potential platform for personalized cancer therapy in metastatic prostate cancer

MLA

Harmen J.G. van de Werken, et al. “Abstract 3919: Liquid Biopsy Derived Organoids as a Potential Platform for Personalized Cancer Therapy in Metastatic Prostate Cancer.” Cancer Research, vol. 80, Aug. 2020, p. 3919. EBSCOhost, https://doi.org/10.1158/1538-7445.am2020-3919.

APA

Harmen J.G. van de Werken, Martijn P. Lolkema, Job van Riet, Jaco Kraan, Lisanne Mout, Nikolas H. Stoecklein, Paul Hamberg, Stefan Sleijfer, John W.M. Martens, Anieta M. Siewerts, Peter A. W. te Boekhorst, Sigrun Erkens-Schulze, Wytske M. van Weerden, Yorick Sandberg, Anouk C. de Jong, Ronald de Wit, Rui P L Neves, & Lisanne F. van Dessel. (2020). Abstract 3919: Liquid biopsy derived organoids as a potential platform for personalized cancer therapy in metastatic prostate cancer. Cancer Research, 80, 3919. https://doi.org/10.1158/1538-7445.am2020-3919

Chicago

Harmen J.G. van de Werken, Martijn P. Lolkema, Job van Riet, Jaco Kraan, Lisanne Mout, Nikolas H. Stoecklein, Paul Hamberg, et al. 2020. “Abstract 3919: Liquid Biopsy Derived Organoids as a Potential Platform for Personalized Cancer Therapy in Metastatic Prostate Cancer.” Cancer Research 80 (August): 3919. doi:10.1158/1538-7445.am2020-3919.